{"id":"rop","safety":{"commonSideEffects":[{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Peripheral edema"},{"rate":null,"effect":"Weight gain"},{"rate":null,"effect":"Elevated triglycerides"}]},"_chembl":null,"_dailymed":{"setId":"a97d5e2d-4a17-4d80-9216-1b0780199502","title":"ROPINIROLE HYDROCHLORIDE TABLET, FILM COATED [A-S MEDICATION SOLUTIONS]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"ROP activates retinoid X receptors, which are nuclear receptors that heterodimerize with other nuclear receptors to control transcription of genes involved in lipid metabolism, glucose homeostasis, and immune regulation. This mechanism allows modulation of metabolic and inflammatory processes relevant to metabolic diseases and certain cancers.","oneSentence":"ROP is a retinoid X receptor (RXR) agonist that modulates nuclear receptor signaling to regulate gene expression involved in metabolic and inflammatory pathways.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:05:37.769Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 2 diabetes (marketed in some regions)"},{"name":"Dyslipidemia"}]},"trialDetails":[{"nctId":"NCT04515524","phase":"","title":"Extension Study to Evaluate the Long-Term Outcomes of Pediatric Patients Who Received Treatment for Retinopathy of Prematurity in the VGFTe-ROP-1920 Study (Acronym: Butterfleye Next)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Regeneron Pharmaceuticals","startDate":"2021-02-05","conditions":"Retinopathy of Prematurity","enrollment":100},{"nctId":"NCT06315556","phase":"","title":"An Observational Study to Collect Data on How Aflibercept (Eylea) Given Using a Paediatric Dosing Device is Used in Preterm Babies With Retinopathy of Prematurity in the United Kingdom (UK)","status":"RECRUITING","sponsor":"Bayer","startDate":"2024-03-05","conditions":"Retinopathy of Prematurity, Preterm Infants","enrollment":200},{"nctId":"NCT05705258","phase":"","title":"A Study to Collect Data on the Use of Eylea in Babies Born Too Early Who Have a Condition of the Eye Where Blood Vessels Grow Abnormally in the Retina (Retinopathy of Prematurity)","status":"RECRUITING","sponsor":"Bayer","startDate":"2023-03-27","conditions":"Retinopathy of Prematurity, Newborns, Infants","enrollment":75},{"nctId":"NCT07427719","phase":"","title":"Retinopathy of Prematurity - Visual Function and Retinal Structure","status":"NOT_YET_RECRUITING","sponsor":"Oslo University Hospital","startDate":"2026-04-01","conditions":"Retinopathy of Prematurity (ROP), Prematurity Complications, Cerebral Visual Impairment","enrollment":140},{"nctId":"NCT04634578","phase":"PHASE2","title":"Bevacizumab Treatment For Type 1 ROP","status":"ACTIVE_NOT_RECRUITING","sponsor":"Jaeb Center for Health Research","startDate":"2022-05-01","conditions":"Retinopathy of Prematurity","enrollment":77},{"nctId":"NCT02820662","phase":"NA","title":"Study of the Implication of Omega-3 Polyunsaturated Fatty Acids in Retinopathy of Prematurity in New-born Infants","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2015-07-30","conditions":"Retinopathy of Prematurity","enrollment":62},{"nctId":"NCT07334652","phase":"NA","title":"Pain and Comfort in the Examination of Retinopathy of Prematurity","status":"ENROLLING_BY_INVITATION","sponsor":"Ataturk University","startDate":"2025-01-01","conditions":"Premature, Retinopaty of Prematurity","enrollment":56},{"nctId":"NCT07312669","phase":"","title":"ROP Check Database Premature Infant Outcomes","status":"COMPLETED","sponsor":"Alaska Blind Child Discovery","startDate":"2010-01-01","conditions":"Retinopathy of Prematurity (ROP)","enrollment":7070},{"nctId":"NCT06517836","phase":"NA","title":"Automated Screening Device to Detect MTMROP","status":"COMPLETED","sponsor":"Siloam Vision","startDate":"2024-10-20","conditions":"Retinopathy of Prematurity, ROP","enrollment":1284},{"nctId":"NCT06109285","phase":"NA","title":"Validation of i-ROP DL to Detect More Than Mild ROP","status":"ACTIVE_NOT_RECRUITING","sponsor":"Siloam Vision","startDate":"2024-06-25","conditions":"Retinopathy of Prematurity, ROP","enrollment":16},{"nctId":"NCT05133999","phase":"","title":"Iron and Retinopathy of Prematurity (ROP)","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2022-04-28","conditions":"Retinopathy of Prematurity","enrollment":175},{"nctId":"NCT04015180","phase":"PHASE3","title":"Extension Study to Evaluate the Long-term Outcomes of Subjects in Study 20090","status":"COMPLETED","sponsor":"Bayer","startDate":"2020-03-18","conditions":"Retinopathy of Prematurity (ROP)","enrollment":100},{"nctId":"NCT05558059","phase":"","title":"Imaging Retinal Vasculature in Infant Eyes","status":"RECRUITING","sponsor":"Duke University","startDate":"2024-10-03","conditions":"Retinopathy of Prematurity","enrollment":16},{"nctId":"NCT04995341","phase":"NA","title":"Retinal Microanatomy in Retinopathy of Prematurity (BabySTEPS2)","status":"RECRUITING","sponsor":"Duke University","startDate":"2021-08-16","conditions":"Retinopathy of Prematurity","enrollment":236},{"nctId":"NCT04819893","phase":"","title":"Study of the Involvement of Fatty Acids in Retinopathy of Prematurity: Relationship Between Retinopathy of Prematurity and the Rate of Expression of Transplacental Fatty Acid Receptors.","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2021-04-20","conditions":"Prematurity, Retinopathy","enrollment":135},{"nctId":"NCT07182513","phase":"","title":"Turkish Version of the Hammersmith Neonatal Neurological Examination (HNNE)","status":"RECRUITING","sponsor":"Kahramanmaras Sutcu Imam University","startDate":"2025-08-22","conditions":"Cerebral Palsy (CP), Infant ALL, Neurological Development","enrollment":120},{"nctId":"NCT06139523","phase":"","title":"Optimize Pediatric OCT Imaging","status":"RECRUITING","sponsor":"Duke University","startDate":"2024-01-24","conditions":"Retinal Disease, Glaucoma, Optic Nerve Diseases","enrollment":30},{"nctId":"NCT03076697","phase":"","title":"Smartphone Screening for Eye Diseases","status":"ENROLLING_BY_INVITATION","sponsor":"University of Michigan","startDate":"2015-04-16","conditions":"Diabetes Mellitus, Glaucoma, Age Related Macular Degeneration","enrollment":550},{"nctId":"NCT07129369","phase":"NA","title":"Effects of a Peer-facilitated, Acceptance-based Self-learning for Illness Management (PASIM) Program","status":"NOT_YET_RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2026-01-02","conditions":"Psychotic Disorders, Recent-Onset Psychosis","enrollment":186},{"nctId":"NCT07127679","phase":"NA","title":"The Effect of Breast Milk on Pain and Stress","status":"COMPLETED","sponsor":"Ege University","startDate":"2024-02-01","conditions":"Breastfeeding, Retinopaty of Prematurity, Pain","enrollment":36},{"nctId":"NCT07112430","phase":"PHASE1, PHASE2","title":"Fentanyl Intranasal for Retinopathy of Prematurity Screening in Preterm Infants","status":"NOT_YET_RECRUITING","sponsor":"IWK Health Centre","startDate":"2025-10-01","conditions":"Neonatal Pain, Retinopathy of Prematurity (ROP), Pain Management","enrollment":50},{"nctId":"NCT07093255","phase":"PHASE1","title":"Safety, PK and PD of FLQ-101 in Premature Neonates","status":"NOT_YET_RECRUITING","sponsor":"FELIQS INC.","startDate":"2025-10-01","conditions":"Retinopathy of Prematurity (ROP)","enrollment":18},{"nctId":"NCT06959290","phase":"NA","title":"Effect of Multiple Non-pharmacological Methods for Pain Management During Eye Examination for Retinopathy of Prematurity in Preterm Infants","status":"COMPLETED","sponsor":"Istanbul Medeniyet University","startDate":"2025-05-01","conditions":"Premature Infant, Retinopaty of Prematurity, Pain Management","enrollment":24},{"nctId":"NCT05304949","phase":"","title":"Regulatory PMS Study for Lucentis® in Patients With Retinopathy of Prematurity","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2022-06-22","conditions":"Retinopathy of Prematurity","enrollment":69},{"nctId":"NCT07016984","phase":"NA","title":"Comfort Level in Premature Infants Undergoing Retinopathy of Prematurity Screening","status":"COMPLETED","sponsor":"Istanbul Nisantasi University","startDate":"2024-01-01","conditions":"Premature, Retinopathy of Prematurity, Pain","enrollment":90},{"nctId":"NCT06612541","phase":"","title":"Point-of-Care Ophthalmic Diagnostic Imaging of Retinopathy of Prematurity","status":"RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2025-02-01","conditions":"Retinopathy of Prematurity (ROP), ROP Examination","enrollment":90},{"nctId":"NCT06940856","phase":"","title":"Chloride Imbalance in Preterm Infants","status":"NOT_YET_RECRUITING","sponsor":"Kanuni Sultan Suleyman Training and Research Hospital","startDate":"2025-04-15","conditions":"Bronchopulmonary Dysplasia (BPD), Mortality Prediction, Chloride Disorder","enrollment":500},{"nctId":"NCT06717412","phase":"NA","title":"Efficacy and Safety of Low-dose Conbercept for Retinopathy of Prematurity Therapy","status":"RECRUITING","sponsor":"Wang Yusheng","startDate":"2024-11-29","conditions":"Retinopathy of Prematurity (ROP)","enrollment":146},{"nctId":"NCT05576792","phase":"","title":"A 24-week Study Evaluating the Effectiveness and Safety of Lucentis® 0.2mg in Retinopathy of Prematurity Participants in China","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2023-01-13","conditions":"Retinopathy of Prematurity","enrollment":62},{"nctId":"NCT06889376","phase":"PHASE1","title":"Use of Intranasal Midazolam to Reduce Stress and Procedural Pain in Premature Infants During Routine ROP Examination.","status":"NOT_YET_RECRUITING","sponsor":"Polish Mother Memorial Hospital Research Institute","startDate":"2025-03-24","conditions":"Drug Safety","enrollment":40},{"nctId":"NCT05043077","phase":"PHASE4","title":"Efficacy and Safety of Mydriatic Microdrops for Retinopathy Of Prematurity Screening","status":"COMPLETED","sponsor":"Aristotle University Of Thessaloniki","startDate":"2021-09-07","conditions":"Retinopathy of Prematurity","enrollment":83},{"nctId":"NCT05100212","phase":"PHASE2","title":"umBilical Or Adult Donor Red Blood Cells in Extremely Low Gestational Age Neonates and Retinopathy of Prematurity (BORN)","status":"COMPLETED","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2021-12-01","conditions":"Retinopathy of Prematurity","enrollment":146},{"nctId":"NCT05666362","phase":"PHASE4","title":"Hemodynamic Response to Pain During Retinopathy Of Prematurity Screening","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2023-01-20","conditions":"Preterm","enrollment":68},{"nctId":"NCT02152046","phase":"","title":"ROP Screening: Comparison of Pain Using Two Eyelid Retractors","status":"TERMINATED","sponsor":"Wake Forest University Health Sciences","startDate":"2014-06-20","conditions":"Pain During ROP Exam","enrollment":44},{"nctId":"NCT06775353","phase":"","title":"To Assess the Effect of Dexamethasone Eye Drops on the Retinopathy of Prematurity Outcome","status":"COMPLETED","sponsor":"Region Skane","startDate":"2022-12-01","conditions":"Retinopathy of Prematurity (ROP)","enrollment":2017},{"nctId":"NCT03083431","phase":"PHASE2","title":"Oral Propranolol for Prevention of Threshold Retinopathy of Prematurity","status":"RECRUITING","sponsor":"University of Zurich","startDate":"2022-09-22","conditions":"Retinopathy of Prematurity","enrollment":276},{"nctId":"NCT06729333","phase":"","title":"A Multicenter and Prospective Study of Screening Retinopathy of Prematurity in China","status":"NOT_YET_RECRUITING","sponsor":"Xinhua Hospital, Shanghai Jiao Tong University School of Medicine","startDate":"2024-12-15","conditions":"Premature Birth of Newborn, Retinopathy of Prematurity (ROP), Low Birthweight Infant","enrollment":5000},{"nctId":"NCT06067958","phase":"PHASE3","title":"Intranasal Dexmedetomidine for Pain Management During Screening for Retinopathy of Prematurity","status":"RECRUITING","sponsor":"Assaf-Harofeh Medical Center","startDate":"2023-12-11","conditions":"Retinopathy of Prematurity, Dexmedetomidine","enrollment":30},{"nctId":"NCT05152862","phase":"","title":"Improve Screening Criteria for Retinopathy of Prematurity in Two French Center","status":"COMPLETED","sponsor":"Centre Hospitalier Sud Francilien","startDate":"2022-03-21","conditions":"Retinopathy of Prematurity","enrollment":886},{"nctId":"NCT06694103","phase":"NA","title":"The Effect of Two Non-Pharmacological Methods on Pain During Retinopathy Examination","status":"RECRUITING","sponsor":"Sinem Basdemir","startDate":"2024-02-19","conditions":"Retinopathy of Prematurity (ROP)","enrollment":84},{"nctId":"NCT06672913","phase":"NA","title":"Impact of Standardized Skin-to-Skin Care on Clinical Outcomes in Infants Born ≤ 32 Weeks: A Multicenter Study","status":"RECRUITING","sponsor":"Baskent University Ankara Hospital","startDate":"2024-09-01","conditions":"Premature, Skin to Skin Contact, Breast Feeding","enrollment":120},{"nctId":"NCT06265363","phase":"","title":"Evaluation of the Frequency, Risk Factors, and Outcomes of ROP in Infants with a BW >1500 Grs or GA ≥33 Wks in Turkey.","status":"RECRUITING","sponsor":"Baskent University Ankara Hospital","startDate":"2023-08-01","conditions":"Retinopathy of Prematurity","enrollment":1000},{"nctId":"NCT06649513","phase":"","title":"Long-term Ophthalmic Outcomes in Ex-premature Infants","status":"NOT_YET_RECRUITING","sponsor":"Erasmus Medical Center","startDate":"2024-11-01","conditions":"Retinopathy of Prematurity (ROP), Premature Birth","enrollment":210},{"nctId":"NCT00895869","phase":"","title":"Pain in Neonates During Screening for Retinopathy of Prematurity Using Two Methods","status":"COMPLETED","sponsor":"NHS Lothian","startDate":"2004-04","conditions":"Retinopathy of Prematurity, Pain","enrollment":76},{"nctId":"NCT03650621","phase":"NA","title":"Acupuncture for Preterm Infants Requiring Eye-exam","status":"COMPLETED","sponsor":"University of Alberta","startDate":"2018-08-24","conditions":"Retinopathy of Prematurity, Pain, Acupuncture","enrollment":100},{"nctId":"NCT04634604","phase":"PHASE3","title":"A Randomized Trial of Low-Dose Bevacizumab vs Laser for Type 1 ROP","status":"TERMINATED","sponsor":"Jaeb Center for Health Research","startDate":"2022-04-27","conditions":"Retinopathy of Prematurity","enrollment":16},{"nctId":"NCT00346814","phase":"PHASE2, PHASE3","title":"Antiangiogenic Therapy With Bevacizumab in Retinopathy of Prematurity. Structural Outcome","status":"RECRUITING","sponsor":"Asociación para Evitar la Ceguera en México","startDate":"2007-07","conditions":"Retinopathy of Prematurity","enrollment":""},{"nctId":"NCT02102711","phase":"NA","title":"Oral Vitamin A Supplementation in Neonates With Birth Weight < 1500 g","status":"COMPLETED","sponsor":"Francesca Garofoli","startDate":"2014-04","conditions":"Bronchopulmonary Dysplasia, Retinopathy of Prematurity","enrollment":62},{"nctId":"NCT06461975","phase":"PHASE3","title":"Effect of Benoxinate Hydrochloride Eye Drops on The Premature Infant Pain Profile Score During Retinopathy of Prematurity Screening","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2023-01-01","conditions":"Retinopathy of Prematurity","enrollment":88},{"nctId":"NCT06452524","phase":"","title":"Prematurity and Ophthalmological Changes","status":"COMPLETED","sponsor":"Ankara City Hospital Bilkent","startDate":"2021-09-01","conditions":"Retinopathy of Prematurity, Myopia","enrollment":211},{"nctId":"NCT03038308","phase":"PHASE1, PHASE2","title":"Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole","status":"COMPLETED","sponsor":"Columbia University","startDate":"2016-09-16","conditions":"Hyperprolactinemia, Prolactinoma","enrollment":16},{"nctId":"NCT00500396","phase":"PHASE4","title":"Vascular Endothelial Growth Factor in Stage V ROP","status":"TERMINATED","sponsor":"Asociación para Evitar la Ceguera en México","startDate":"2007-03","conditions":"Retinopathy of Prematurity","enrollment":15},{"nctId":"NCT00563121","phase":"PHASE4","title":"VEGF Levels in Aqueous, Vitreous and Subretinal Fluid in ROP Stage IV and V","status":"WITHDRAWN","sponsor":"Asociación para Evitar la Ceguera en México","startDate":"2007-03","conditions":"Retinopathy of Prematurity","enrollment":""},{"nctId":"NCT06044181","phase":"NA","title":"Peripheral Avascular Retina in Retinopathy of Prematurity","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2024-01-01","conditions":"Retinopathy of Prematurity","enrollment":32},{"nctId":"NCT06348641","phase":"NA","title":"Reducing Pain and Increasing Comfort During a Retinopathy of Prematurity Examination","status":"NOT_YET_RECRUITING","sponsor":"Nurgül Tekin","startDate":"2024-04-20","conditions":"Pain, Retinopathy of Prematurity, Premature Baby 26 to 32 Weeks","enrollment":60},{"nctId":"NCT05387941","phase":"PHASE1","title":"Pharmacokinetics and Safety of Dexamethasone Eye Drops in Preterm Infants","status":"RECRUITING","sponsor":"Region Skane","startDate":"2022-06-14","conditions":"Retinopathy of Prematurity","enrollment":15},{"nctId":"NCT06288321","phase":"EARLY_PHASE1","title":"A Study Investigating Whether Low Dose Eyedrops for Pupil Dilation is as Effective and Safe as Standard Dose Eyedrops in Examination for Retinopathy of Prematurity.","status":"COMPLETED","sponsor":"The University of Hong Kong","startDate":"2022-08-10","conditions":"Retinopathy of Prematurity","enrollment":18},{"nctId":"NCT03830580","phase":"NA","title":"Benefit of Singing in the Care of Premature Children Undergoing Screening for Retinopathy of Prematurity in the Neonatology and Neonatal Resuscitation Unit of the Dijon University Hospital","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2019-02-06","conditions":"Prematurity, Eye Fundus","enrollment":40},{"nctId":"NCT04939571","phase":"","title":"European Disease Registry on Retinopathy of Prematurity (ROP)","status":"RECRUITING","sponsor":"University Medicine Greifswald","startDate":"2021-08-06","conditions":"Retinopathy of Prematurity","enrollment":3000},{"nctId":"NCT05967572","phase":"NA","title":"The Effect of Different Music Listened During Retinopathy Examination to Premature Infants","status":"UNKNOWN","sponsor":"Necmettin Erbakan University","startDate":"2023-06-01","conditions":"Retinopathy of Prematurity, Newborn","enrollment":84},{"nctId":"NCT00870636","phase":"","title":"Use of Pan-vascular Endothelial Growth Factor Receptor (Pan-VEGF) Blockade for the Treatment of Retinopathy of Prematurity (ROP) (Compassionate Use BLOCK-ROP)","status":"NO_LONGER_AVAILABLE","sponsor":"Children's Hospital Los Angeles","startDate":"","conditions":"Retinopathy of Prematurity","enrollment":""},{"nctId":"NCT05203159","phase":"NA","title":"The Effect of Ocean Sound In Premature Retinopathy Examination","status":"COMPLETED","sponsor":"Necmettin Erbakan University","startDate":"2021-11-25","conditions":"Premature Retinopathy, Pain","enrollment":44},{"nctId":"NCT05438680","phase":"NA","title":"Bovine Colostrum in Prevention of Sepsis and Retinopathy of Prematurity","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2022-06-20","conditions":"Preterm","enrollment":200},{"nctId":"NCT05263973","phase":"NA","title":"The Effect of Music on Pain, Comfort and Physiological Parameters During Prematurity Retinopathy Examination","status":"COMPLETED","sponsor":"TC Erciyes University","startDate":"2022-03-10","conditions":"ROP Examination","enrollment":28},{"nctId":"NCT06063863","phase":"NA","title":"Feasibility of Nurse-led Retinal Imaging for Retinopathy of Prematurity Screening Employing the Optos California","status":"COMPLETED","sponsor":"University of Nottingham","startDate":"2021-05-10","conditions":"Retinopathy of Prematurity","enrollment":52},{"nctId":"NCT05782101","phase":"","title":"Integrated Proteomic HPLC-ESI-MS Analysis of Salivary Peptides of Preterm Newborns: a Pilot Study","status":"COMPLETED","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2022-02-17","conditions":"Bronchopulmonary Dysplasia; Retinopathy of Prematurity","enrollment":30},{"nctId":"NCT01993043","phase":"","title":"39946-I Laser and Bevacizumab Treatment for Retinopathy of Prematurity","status":"COMPLETED","sponsor":"Baylor College of Medicine","startDate":"2010-10","conditions":"ROP Threshold","enrollment":150},{"nctId":"NCT02814929","phase":"","title":"Incidence, Risk Factors and Severity of Retinopathy of Prematurity (ROP) in Turkey","status":"COMPLETED","sponsor":"Etlik Zubeyde Hanım Women's Health Care, Training and Research Hospital","startDate":"2016-04-01","conditions":"Retinopathy of Prematurity","enrollment":6115},{"nctId":"NCT04101721","phase":"PHASE3","title":"Study to Assess the Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Compared to Laser Photocoagulation in Patients With Retinopathy of Prematurity","status":"COMPLETED","sponsor":"Regeneron Pharmaceuticals","startDate":"2019-10-30","conditions":"Retinopathy of Prematurity","enrollment":127},{"nctId":"NCT05880433","phase":"","title":"The Effects of Mydriatic Eye Drops in Retinopathy of Prematurity Examinations","status":"COMPLETED","sponsor":"Istanbul Training and Research Hospital","startDate":"2021-05-01","conditions":"Retinopathy of Prematurity, Mydriasis, Neonatal Disease","enrollment":62},{"nctId":"NCT05144282","phase":"","title":"The Analysis of Association of Retinopathy of Prematurity, Gut Microbiome Profile, and Systemic Inflammation","status":"UNKNOWN","sponsor":"Chang Gung Memorial Hospital","startDate":"2020-08-15","conditions":"Retinopathy of Prematurity, Microbiome","enrollment":240},{"nctId":"NCT05132257","phase":"","title":"Genetic Polymorphism and Retinopathy of Prematurity: Correlation of Clinical Presentations and Severity","status":"UNKNOWN","sponsor":"Chang Gung Memorial Hospital","startDate":"2021-04-12","conditions":"Retinopathy of Prematurity, Genetic Polymorphism","enrollment":500},{"nctId":"NCT05806684","phase":"","title":"Hyperbilirubinemia and Retinopathy of Prematurity in Preterm Infants: a Retrospective Study.","status":"UNKNOWN","sponsor":"Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico","startDate":"2023-05-01","conditions":"ROP, Jaundice, Neonatal, Premature","enrollment":1586},{"nctId":"NCT02640664","phase":"PHASE3","title":"Rainbow Extension Study","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2016-06-16","conditions":"Retinopathy of Prematurity (ROP)","enrollment":180},{"nctId":"NCT02887157","phase":"","title":"Analyzing Retinal Microanatomy in ROP","status":"COMPLETED","sponsor":"Duke University","startDate":"2016-07-22","conditions":"Retinopathy of Prematurity, Neurodevelopmental Disorders, Macular Edema","enrollment":191},{"nctId":"NCT05099588","phase":"","title":"The Incidence of Treatment-requiring Retinopathy of Prematurity in Greece","status":"COMPLETED","sponsor":"Aristotle University Of Thessaloniki","startDate":"2020-06-01","conditions":"Retinopathy of Prematurity","enrollment":43},{"nctId":"NCT04621136","phase":"PHASE1, PHASE2","title":"PhaseI/II Investigator-Initiated Trial to Investigate Safety and Efficacy of Ripasudil in Patients With Retinopathy of Prematurity","status":"COMPLETED","sponsor":"Kyushu University","startDate":"2020-11-01","conditions":"Retinopathy of Prematurity","enrollment":24},{"nctId":"NCT05712642","phase":"PHASE3","title":"A Dosing Study of Intravitreal Bevacizumab for Retinopathy of Prematurity","status":"COMPLETED","sponsor":"Cairo University","startDate":"2020-02-01","conditions":"Retinopathy of Prematurity","enrollment":19},{"nctId":"NCT05701124","phase":"PHASE3","title":"Intravitreal Ranibizumab Injection for Aggressive Versus Type 1 Prethreshold Retinopathy of Prematurity","status":"COMPLETED","sponsor":"Zagazig University","startDate":"2020-11-20","conditions":"Retina Disease, Retinopathy of Prematurity, Ranibizumab","enrollment":30},{"nctId":"NCT02486042","phase":"PHASE2","title":"Omega-3 Long Chain Polyunsaturated Fatty Acid (LCPUFA) Supplementation in Very Low Birth Weight Infants for The Prevention Retinopathy of Prematurity","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2014-03","conditions":"Retinopathy of Prematurity","enrollment":48},{"nctId":"NCT02390531","phase":"PHASE1","title":"Phase 1 Trial of Bevacizumab Treatment for Severe Retinopathy of Prematurity","status":"COMPLETED","sponsor":"Jaeb Center for Health Research","startDate":"2015-04-28","conditions":"Retinopathy of Prematurity","enrollment":120},{"nctId":"NCT04985448","phase":"","title":"Real World Study of the Effectiveness and Safety of Conbercept Ophthalmic Injection in the Treatment of Retinopathy of Prematurity - Multicenter, Retrospective and Observational Study Based on Real World Data","status":"UNKNOWN","sponsor":"Chengdu Kanghong Biotech Co., Ltd.","startDate":"2022-09","conditions":"Retinopathy of Prematurity","enrollment":1000},{"nctId":"NCT04092127","phase":"","title":"Pain of Premature Babies and RetCam (DOLICAM)","status":"COMPLETED","sponsor":"University Hospital, Grenoble","startDate":"2019-11-12","conditions":"Premature Infant Disease, Retinopathy of Prematurity","enrollment":31},{"nctId":"NCT02386839","phase":"PHASE2","title":"Long-term Safety and Efficacy Outcome Study Comparing Children Previously Enrolled in Study ROPP-2008-01 for the Prevention of Retinopathy of Prematurity (ROP)","status":"COMPLETED","sponsor":"Shire","startDate":"2015-03-26","conditions":"Retinopathy of Prematurity (ROP)","enrollment":76},{"nctId":"NCT04004208","phase":"PHASE3","title":"Aflibercept for Retinopathy of Prematurity - Intravitreal Injection Versus Laser Therapy","status":"COMPLETED","sponsor":"Bayer","startDate":"2019-09-25","conditions":"Retinopathy of Prematurity (ROP)","enrollment":113},{"nctId":"NCT04902859","phase":"PHASE4","title":"Clonidine as Pain Relief During ROP Eye Examinations","status":"UNKNOWN","sponsor":"Region Örebro County","startDate":"2022-04-25","conditions":"Retinopathy of Prematurity, Pain, Procedural, Premature Infant Disease","enrollment":50},{"nctId":"NCT05354479","phase":"PHASE4","title":"Breastmilk Alone or in Combination With Paracetamol for Reducing Pain","status":"UNKNOWN","sponsor":"Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh","startDate":"2021-10-20","conditions":"Pain Control","enrollment":60},{"nctId":"NCT04420156","phase":"","title":"Clinical and Genetic Analysis of ROP","status":"RECRUITING","sponsor":"Oregon Health and Science University","startDate":"2011-07-01","conditions":"Retinopathy of Prematurity","enrollment":2000},{"nctId":"NCT04623684","phase":"PHASE4","title":"Efficacy and Safety of Mydriatic Microdrops Compared With Standard Drops for Retinopathy of Prematurity (ROP) Screening: a Pilot Randomized Clinical Trial","status":"COMPLETED","sponsor":"Aristotle University Of Thessaloniki","startDate":"2020-03-24","conditions":"Retinopathy of Prematurity","enrollment":25},{"nctId":"NCT04408807","phase":"NA","title":"Stress Induced by Screening for Retinopathy of Prematurity - Should Speculum and Indentation Rather be Avoided","status":"COMPLETED","sponsor":"Aristotle University Of Thessaloniki","startDate":"2019-09-03","conditions":"Retinopathy of Prematurity","enrollment":37},{"nctId":"NCT04883931","phase":"NA","title":"Mother Milk as a Eye Drop & Premature Retinopathy","status":"COMPLETED","sponsor":"Baskent University","startDate":"2021-05-06","conditions":"Retinopathy of Prematurity","enrollment":101},{"nctId":"NCT02570503","phase":"PHASE4","title":"Postoperative Pain Control After Periarticular Injection During Total Knee Arthroplasty","status":"TERMINATED","sponsor":"Virginia Commonwealth University","startDate":"2015-10","conditions":"Osteoarthritis, Knee","enrollment":64},{"nctId":"NCT05186155","phase":"","title":"Analysis of Ocular and Neurodevelopmental Function for Retinopathy of Prematurity","status":"UNKNOWN","sponsor":"Chang Gung Memorial Hospital","startDate":"2019-01-01","conditions":"Retinopathy of Prematurity, Neurodevelopmental Abnormality","enrollment":510},{"nctId":"NCT00383019","phase":"PHASE3","title":"A Study Comparing Xalacom And Xalatan In Patients With Primary Open Angle Glaucoma (POAG) Or Ocular Hypertension (OH).","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2006-11-14","conditions":"Glaucoma, Ocular Hypertension","enrollment":300},{"nctId":"NCT05033106","phase":"PHASE3","title":"Ranibizumab Vs Bevacizumab for Type 1 Retinopathy of Prematurity","status":"UNKNOWN","sponsor":"Zagazig University","startDate":"2020-09-01","conditions":"Retinopathy of Prematurity Both Eyes","enrollment":36},{"nctId":"NCT05010252","phase":"NA","title":"The Effect of Cycled Light on Premature Infants and Mothers","status":"UNKNOWN","sponsor":"National Taiwan University Hospital","startDate":"2021-04-16","conditions":"Preterm Infant Development, Retinopathy of Prematurity, Sleep Quality","enrollment":320},{"nctId":"NCT04463927","phase":"NA","title":"The Effect of Non-nutritive Sucking on Pain During Examination for Retinopathy of Prematurity","status":"COMPLETED","sponsor":"Adiyaman University Research Hospital","startDate":"2020-05-10","conditions":"Pain","enrollment":60},{"nctId":"NCT01780155","phase":"","title":"Genes Associated With Bronchopulmonary Dysplasia and Retinopathy of Prematurity","status":"COMPLETED","sponsor":"National Institute of Environmental Health Sciences (NIEHS)","startDate":"2013-06-24","conditions":"Bronchopulmonary Dysplasia, Retinopathy of Prematurity, Prematurity","enrollment":1068},{"nctId":"NCT01096784","phase":"PHASE2","title":"IGF-1/IGFBP3 Prevention of Retinopathy of Prematurity","status":"COMPLETED","sponsor":"Shire","startDate":"2010-06-18","conditions":"Retinopathy of Prematurity (ROP)","enrollment":121},{"nctId":"NCT04769661","phase":"","title":"Role of Cord Blood Cytokines and Perinatal Factors in Prediction of Retinopathy of Prematurity","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2021-05-01","conditions":"Retinopathy of Prematurity","enrollment":50}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"NEPHROLITHIASIS"}],"_approvalHistory":[],"publicationCount":8123,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"ROP","genericName":"ROP","companyName":"GlaxoSmithKline","companyId":"glaxosmithkline","modality":"Small molecule","firstApprovalDate":"","aiSummary":"ROP is a retinoid X receptor (RXR) agonist that modulates nuclear receptor signaling to regulate gene expression involved in metabolic and inflammatory pathways. Used for Type 2 diabetes (marketed in some regions), Dyslipidemia.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}